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Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) has emerged as a major nosocomial 
pathogen that is widespread in both health care facilities and the community at large as a result of 
direct host-to-host transmission. Several virulence factors are associated with pathogen 
transmission to naive hosts. Immunodominant surface antigen B (IsaB) is a virulence factor that 
helps Staphylococcus aureus to evade the host defense system. However, the mechanism of IsaB 
on host transmissibility remains unclear. We found that IsaB expression was elevated in 
transmissible MRSA. Wild-type isaB strains inhibited autophagic flux to promote bacterial 
survival and elicit inflammation in THP-1 cells and mouse skin. MRSA isolates with increased 
IsaB expression showed decreased autophagic flux, and the MRSA isolate with the lowest IsaB 
expression showed increased autophagic flux. In addition, recombinant IsaB rescued the virulence 
of the isaB deletion strain and increased the Group A streptococcus (GAS) virulence in vivo. 
Together, these results reveal that IsaB diminishes autophagic flux, thereby allowing MRSA to 
evade host degradation. These findings suggest that IsaB is a suitable target for preventing or 
treating MRSA infection.
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INTRODUCTION
For several decades, MRSA has been recognized as a leading cause of nosocomial infections 
worldwide (Chatterjee and Otto, 2013; Hogea et al., 2013). MRSA infections occur 
predominantly in hospitals, in which case they are called hospital acquired-MRSA (HA-
MRSA); however, the incidence of community-acquired MRSA (CA-MRSA) infections has 
been increasing (Jappe et al., 2008; Otto, 2010; Xia et al., 2013). MRSA can spread to the 
bloodstream and cause sepsis, a leading cause of shock and circulatory collapse (Tarkowski 
et al., 2001). MRSA can also spread to other organs, including the lung, kidney, liver, 
spleen, heart and bones, which results in severe infections such as urethritis, pneumonia, 
endocarditis and osteomyelitis (Haim et al., 2010). MRSA is becoming increasingly difficult 
to treat because multidrug-resistant strains of MRSA are on the rise, leading to high 
mortality rates in humans (Westling, 2009). The increasing morbidity and mortality 
associated with MRSA infections have motivated researchers to make MRSA prevention 
and therapy a priority. Transmission between hosts is a vital aspect of the biology of any 
commensal or pathogenic microorganism (Massey et al., 2006). For example, pathogenic 
bacteria utilize virulence factors that attack or allow evasion of the host antimicrobial 
defense system, promoting bacterial survival and allowing infection of the host (Kassegne et 
al., 2014; Liu et al., 2009; Lo et al., 2011; Ogawa et al., 2011; Orvedahl and Levine, 2009; 
Otto, 2012). In addition, virulence factors may be required for the transmission of pathogens 
to naive hosts (Wickham et al., 2007).
Autophagy is a ‘self-eating’ pathway that generates autophagosomes and delivers abnormal 
organelles or misfolded proteins to lysosomes for degradation during stress or nutrient 
deprivation (Mizushima et al., 2008). Autophagy serves as an antimicrobial defense 
mechanism that eliminates invading bacteria (a process called xenophagy) and plays a 
crucial role in host cell resistance to infection (Knodler and Celli, 2011; Parihar et al., 2014). 
Although the precise mechanisms of autophagy on bacteria remain unclear, autophagosomes 
and phagosomes are involved in recruiting intracellular bacteria into lysosomes for bulk 
degradation (Levine et al., 2011; Petruccioli et al., 2012). In contrast, invading bacteria 
express virulence factors that attenuate host autophagic flux and allow escape from host 
attack: for example, IcsB of Shigella flexneri and the deubiquitinase SseL of Salmonella 
Typhimurium (Ogawa et al., 2005) (Mesquita et al., 2012). Furthermore, S. flexneri 
expresses the T3SS effector IcsB, which interferes with the binding between the surface 
protein VirG and the host protein ATG5 and thereby allows S. flexneri to avoid targeting by 
host autophagy (Ogawa et al., 2005). Ssel, a deubiquitinase of Salmonella, reduces 
ubiquitinated aggregates and eliminates recruitment of the autophagy adaptor SQSTM1, 
which in turn evades host autophagy degradation and promotes Salmonella replication in 
cells (Mesquita et al., 2012). Interestingly, S. aureus employees autophagosomes to replicate 
in human cervical cancer HeLa cells or fibroblast cells (Schnaith et al., 2007), indicating 
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that autophagy is detrimental to these host cells during S. aureus infection. Nevertheless, 
autophagy is induced to degrade intracellular bacteria and serves as a safeguard for host 
cells during S. aureus infection (Amano et al., 2006; Mauthe et al., 2012), suggesting that 
the role of autophagy in S. aureus infections is not fully understood.
S. aureus immunodominant surface antigen B (IsaB) is classified as both a secreted and a 
cell-surface associated virulence factor, and it elicits an immune response during septicemia 
(Mackey-Lawrence et al., 2009). Analysis of global transcripts showed that isaB expression 
is induced in response to certain conditions and factors such as the presence of glucose, 
human serum, plasma (Mackey-Lawrence and Jefferson, 2013a), biofilms, neutrophil 
exposure, anaerobic conditions, bacteremia and infections, and following internalization by 
human epithelial cells, suggesting a role in immune evasion and virulence (Fuchs et al., 
2007; Garzoni et al., 2007; Resch et al., 2005; Voyich et al., 2005). However, the role of 
IsaB in the autophagy of MRSA-infected cells and in the transmission of MRSA is not 
defined. In this study, we found that the expression of the IsaB virulence factor was elevated 
in transmissible MRSA. IsaB was involved in susceptibility to MRSA infection and 
inflammation via inhibition of autophagic flux in both human macrophage-like THP-1 cells 
and in vivo. Moreover, group A streptococcus (GAS), an invading pathogen that is easily 
degraded by host autophagy, became more virulent in cells treated with recombinant IsaB. 
Our study suggests that IsaB is a suitable target for preventing and treating MRSA infection.
RESULTS
IsaB expression is induced in transmissible MRSA strain in vivo
To compare the virulence of MRSA with and without host transmissibility, transmissible 
MRSA strain was isolated. After one host transmission of MRSA [MRSA(1)], severe ear 
inflammation (Figure 1a) and increased secretion of macrophage inflammatory peptide 
(MIP)-2 from skin tissue were observed in mice at day 5 post-infection (Figure 1b), in 
addition to a more than 100-fold increase in bacterial colonization of the ear skin (Figure 1c) 
over infection with parental MRSA [MRSA(0)]. These results suggest that after host 
transmission, MRSA became more virulent and caused severe skin inflammation and 
bacterial colonization. Because expression of IsaB is increased during S. aureus infection 
(Mackey-Lawrence and Jefferson, 2013a), we examined IsaB expression in transmissible 
MRSA by immunoblotting with the antibody generated against purified recombinant IsaB 
(Figure S1). The recombinant IsaB was validated by sequencing using nano-liquid 
chromatography linear trap quadrupole tandem mass spectrometry. Thirty-eight peptides 
were fully sequenced, and these matched well with the internal amino acids of MRSA IsaB 
(Table S1). We found that the expression level of IsaB was increased in transmissible 
MRSA (1) compared to that in parental MRSA (0) (Figure 1d). These results indicate that 
the virulence factor IsaB may be involved in MRSA host transmissibility.
IsaB diminishes autophagic flux to enhance bacterial survival in cells
Autophagy plays a crucial role on the clearance of invading bacteria from host cells (Gong 
et al., 2012; Levine et al., 2011). To examine the potential mechanisms of virulence factor 
IsaB on MRSA transmissibility, wild-type and isogenic isaB deletion strains were used to 
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infect human HeLa cells harboring GFP-MAP1LC3. Autophagy induction increases the 
number and intensity of small MAP1LC3-II puncta, whereas blocking the downstream steps 
of autophagosomes or lysosomes development not only increases the surface area and 
intensity of MAP1LC3-II puncta in the cytoplasm but also causes them to aggregate around 
the nuclear membrane (Zhang et al., 2007). We included rapamycin and bafilomycin A1 
(BafA1) as controls for autophagic flux induction and inhibition, respectively (Figure 2a and 
2b). In contrast, wild-type isaB strain apparently increased the surface area and intensity of 
GFP-MAP1LC3-II puncta in the cells (Figure 2a). HeLa cells harboring RFP-GFP-
MAP1LC3 were further employed to inspect the role of IsaB on autophagic flux. Because 
GFP is quenched in acidic environments, such as that in an autolysosome, the RFP+GFP+ 
puncta and RFP+GFP− puncta were considered to be autophagosomes and autolysosomes, 
respectively (Zhou et al., 2012). The cells infected with wild-type strain had relatively fewer 
autolysosomes (RFP+GFP−) compared to the cells infected with isaB deletion strain (Figure 
2b and 2c). Next, we examined MAP1LC3-II and SQSTM1 degradation in infected THP-1 
cells cultured with or without chloroquine (CQ, an autophagic flux inhibitor) to determine 
the effect of IsaB on autophagic flux in host cells, as described previously (Liu et al., 2014). 
MAP1LC3-II and SQSTM1 proteins were accumulated in THP-1 cells when infected with 
wild-type strain (Figure 2d and 2e), indicating that IsaB may inhibit autophagic flux in host 
cells. To determine colocalization between bacteria and lysosomes, HeLa cells expressing 
the lysosomal marker Lamp1-RFP (Figure 3a) were infected with bacteria that were labeled 
with SYTO green fluorescent dye. The number of intracellular bacteria was increased in 
HeLa cells that were pretreated with BafA1, while the percentage of lysosomes colocalized 
with bacteria was reduced in these cells (Figure 3a and 3b). Furthermore, the survival of 
isaB deletion strain in THP-1 cells was significantly decreased (Figure 3c and 3d). The 
decreased bacterial survival of isaB deletion strain was recovered in both cells by 
pretreatment with rapamycin and BafA1 (Figure 3c, 3d, and 3e). However, silencing Atg5 
and Ulk1, which are both essential genes for autophagosome formation, did not restore 
bacterial survival of isaB deletion strain in THP-1 cells (Figure S2), implying that IsaB may 
block autophagic flux and allow bacteria to survive in cells. We also found that TNF-α 
secretion was diminished in THP-1 cells infected with the isaB deletion strain compared 
with wild-type strain (Figure 3f). The mRNA levels of Tnf− α and Il-8 were reduced in the 
cells infected with isaB deletion mutant (Figure 3g), suggesting that IsaB may diminish 
autophagic flux, enhances the survival of S. aureus, and thereby elicit inflammation in host. 
More interestingly, clinical MRSA isolates expressing higher levels of IsaB accumulated 
more SQSTM1 protein and displayed less autophagic flux in THP-1 cells than MRSA (C1), 
which had the lowest IsaB expression level out of the 5 MRSA clinical isolates tested in this 
study (Figure 4). Moreover, production of the inflammatory cytokine TNF-α and mRNA 
levels of Tnf-α and Il-8 in the infected THP-1 cells were negatively correlated with 
autophagic activity (Figure 4), supporting the notion that IsaB may reduce autophagic flux 
and thereby allow MRSA to survive in the host cells. In addition to the role of bacterial 
virulence factors in autophagy, they are also involved in the induction of immune cell death, 
which may be important for bacterial survival and escape from host immune defense (Haim 
et al., 2010; Sumpter and Levine, 2010). Indeed, apoptosis was increased in macrophages 
infected with strains expressing high levels of IsaB (Figure S3a and S3b). By contrast, 
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recombinant IsaB had no effect on apoptosis in macrophages (Figure S3c), suggesting that 
IsaB may have an additional role on cytotoxicity when bacteria are internalized into cells.
The wild-type isaB strain inhibits autophagic flux and increases survival in vivo
To examine the involvement of IsaB in MRSA virulence in vivo, mice ears were injected 
with a wild-type isaB strain or deletion strain and skin lesions were used as an indication of 
inflammation. At day 3, the ears injected with isaB deletion strain displayed significantly 
less inflammation than mice whose ears were injected with the wild-type strain (Figure 5a, 
WT). Next, the mouse ears injected with either the wild-type strain or isaB-deletion strain 
were excised and homogenized to assess bacterial colonization (Figure 5b), and 
immunoblotting of MAP1LC3 and SQSTM1 was conducted to assess host autophagic flux 
(Figure 5c and 5d). The survival of isaB-deletion strain was much lower than that of the 
wild-type strain in vivo (Figure 5b). In contrast to mouse ears infected with the isaB-deletion 
mutant, those infected with the wild-type strain showed increased accumulation of SQSTM1 
and lapidated MAP1LC3-II, further confirming that IsaB inhibits host autophagic flux in 
vivo (Figure 5c and 5d). The lesion size and bacterial survival in mouse dorsal skin was also 
significantly reduced in the mice injected with the isaB deletion strain (Figure 5e and 5f). 
These results further support the notion that IsaB is involved in modulating autophagic flux 
to promote bacterial survival and elicit the host inflammatory response.
Recombinant IsaB inhibits autophagic flux in vitro and enhances bacterial colonization in 
vivo
To examine the role of IsaB on autophagic flux, cells were treated with recombinant MRSA 
IsaB and then assessed for MAP1LC3-II puncta accumulation, with BafA1 used as the 
positive control. We found that treatment with recombinant IsaB led to the accumulation of 
MAP1LC3-II puncta in a dose-dependent manner (Figure 6a). Likewise, recombinant IsaB 
resulted in significant accumulation of autophagic markers, including GFP-MAP1LC3-II, 
GFP and SQSTM1, in infected MEF stably expressing GFP-MAP1LC3 (Mizushima et al., 
2010) (Figure 6b). Interestingly, the decreased lesion size in the mice skin that were infected 
with the isaB deletion strain was significantly restored when the mice were injected with 
recombinant IsaB, whereas recombinant GFP had little effect on virulence reconstitution 
(Figure 6c). Similar results were observed for bacterial colony formation (Figure 6d). 
Because intracellular GAS are degraded by host autophagy within 5 h post-infection 
(Yamaguchi et al., 2009), we hypothesized that exogenous MRSA IsaB might promote GAS 
virulence. Indeed, the lesion size and number of GAS colonies were significantly increased 
when mice were injected with recombinant IsaB compared to injections with recombinant 
GFP (Figure 6e and 6f), revealing that the virulence factor IsaB may inhibit autophagic flux 
and thereby eradicate bacterial degradation in vivo. Furthermore, the number of MRSA(1) 
colonies and lesion size in the ears and dorsal skin of IsaB-immunized mice were 
significantly lower than in GFP-immunized mice (Figure S4 and S5). These results show 
that IsaB is a potential vaccine for the MRSA.
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DISCUSSION
MRSA infection remains a significant threat to human health in the second decade of the 
21st century. It is widely accepted that increased virulence of MRSA is associated with 
increased transmissibility (Massey et al., 2006). Virulence factors of MRSA strains have 
been reported to attenuate antimicrobial systems in host cells (Kraus and Peschel, 2008). 
Although several antibiotics are used to treat MRSA infection, multidrug-resistant strains of 
MRSA are a growing threat to public health (Han et al., 2007). Therefore, increasing our 
understanding of how MRSA virulence factors counteract host antimicrobial mechanisms 
can provide critical insight into the pathogenesis of MRSA and may advance preventive and 
therapeutic strategies. In this study, we report the following findings. First, the level of IsaB 
is elevated in transmissible MRSA(1), which is more virulent than parental MRSA(0). 
Second, elevated IsaB inhibits host autophagic flux and increase MRSA survival, thereby 
eliciting inflammation in both cell culture and animal models. Third, recombinant IsaB 
inhibits autophagic flux and increases host susceptibility to infection with GAS. These 
findings shed light on the virulence mechanisms of IsaB in skin pathogenesis during MRSA 
infection.
Autophagy is an innate antimicrobial defense mechanism that eliminates intracellular 
bacteria and reduces excessive inflammation in host cells (Petruccioli et al., 2012). Some 
bacteria have developed strategies to avoid degradation by host autophagic responses. These 
bacteria express virulence factors that block autophagy by inhibiting essential molecules or 
steps in autophagy, such as the ATG protein, autophagic recognition (Sumpter and Levine, 
2010; Yoshikawa et al., 2009), and membrane (autophagosome and lysosome) fusion (Gong 
et al., 2012). However, the role of autophagy can be either beneficial or detrimental to host 
cells during S. aureus infection. S. aureus becomes trapped and is degraded in 
autophagosomes in human osteosarcoma U2OS cells (Mauthe et al., 2012), but accessory 
gene regulator (agr), a virulence factor, is involved in inducing autophagosomes to form a 
niche for S. aureus replication in HeLa cells (Schnaith et al., 2007). Our current data show 
that the level of IsaB is elevated in transmissible MRSA and that IsaB may negatively 
regulate autophagic flux in human macrophage-like THP-1 cells. Clinical MRSA isolates 
expressing high levels of IsaB also display reduced autophagic flux, increased survival, and 
elevated inflammatory cytokine production, in line with previous findings showing that 
autophagic flux is beneficial for host degradation of MRSA (Amano et al., 2006; Mauthe et 
al., 2012). Regarding the role of IsaB in autophagic flux, our study found that BafA1 largely 
rescued the survival of isaB deletion strain in THP-1 cells, whereas autophagy inhibition by 
RNAi had minimal effects on bacterial survival in the cells. BafA1, an inhibitor of vacuolar 
H+-ATPase, has been found to inhibit the acidification of lysosomes and further block the 
fusion of autophagosomes with lysosomes (Klionsky et al., 2008). IsaB expression in S. 
aureus is induced in acidic environments (pH 4-5) (Garzoni et al., 2007; Mackey-Lawrence 
and Jefferson, 2013b), implying that elevated IsaB in MRSA may prevent lysosomal 
acidification and indirectly impair autophagic flux. However, further study is required to 
determine the detailed mechanisms of IsaB on autophagy regulation in host cells.
Autophagy modulates pro-inflammatory transcription factors and IL-1β activation and 
secretion to suppress inflammation (Dupont et al., 2011; Harris et al., 2011; Yuk and Jo, 
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2013). Our results show that IsaB induces the production of the inflammatory cytokines 
TNF-α and IL-8, but not the activation or secretion of IL-1β (data not shown), suggesting 
that IsaB-inhibited autophagic flux may enhance the ability of pro-inflammatory 
transcription factors to augment inflammation. In addition to autophagy, immune cell death 
is also involved in pathogenic factor-induced inflammation. Our results also show that 
strains expressing high levels of IsaB induce apoptosis in macrophages. IsaB expression is 
elevated when S. aureus is internalized into human cells or exposed to neutrophils (Garzoni 
et al., 2007; Voyich et al., 2005). Neutrophils are the immune cells that immediately migrate 
to infected sites to kill S. aureus, mainly through opsonophagocytosis (van Kessel et al., 
2014), implying that IsaB may play a role in opsonophagocytosis of neutrophils. 
Nevertheless, understanding the role of IsaB in neutrophil-mediated opsonophagocytosis 
will require further study aimed at clarifying these missing links.
In this study, we observed elevated levels of IsaB in transmissible MRSA. Elevated IsaB 
inhibits host autophagic flux and promotes MRSA virulence. Immunization with IsaB 
effectively protects mice from skin lesions caused by MRSA(1). Of note, IsaB is a secreted 
or cell surface virulence factor widely expressed in most strains of S. aureus, including 
MRSA and MSSA (Mackey-Lawrence and Jefferson, 2013a; Mackey-Lawrence et al., 
2009). Thus, our study suggests that IsaB is a potential target for preventing or treating S. 
aureus infection, which could greatly benefit human health.
MATERIALS AND METHODS
Isolation of the transmissible MRSA252 strain
Female ICR mice (3 to 6 weeks old; Harlan) were maintained at the University of 
California, San Diego (UCSD), in accordance with institutional guidelines. MRSA252 (25 
μl in PBS; 1 × 107 CFU), or 25 μl of PBS, used as a negative control, was subcutaneously 
injected into the central portion of the left ear of mice. Infected ear skin was harvested and 
homogenized on day 3 after infection. The homogenate was plated on tryptic soy agar to 
pick bacterial colonies for further experiments. The MRSA252 strain before host 
transmission was named MRSA(0) and MRSA252 after one generation of host transmission 
was named MRSA(1). All animal experiments were approved by UCSD Institutional 
Animal Care and Use committee.
Bacterial and cell culture
The MRSA252 strain, wild-type S. aureus 10833 strain, isaB deletion 10833ΔisaB::erm 
strain (with erythromycin antibiotic), and clinical MRSA isolates were cultured in 3% (w/v) 
trypticase soy broth (Sigma-Aldrich) under aerobic conditions at 37°C overnight with 
shaking (250 rpm). Human macrophage-like THP-1 cells were cultured in RPMI-1640 
Medium (Invitrogen) and infected with bacteria for assessment of bacterial survival, 
inflammatory cytokine production and immunoblotting. MEF cells that stably expressing 
GFP-MAP1LC3 and human cervical cancer HeLa cells transfected with RFP-GFP-
MAP1LC3, LAMP1-RFP or GFP-MAP1LC3 were cultured in DMEM (Invitrogen) and 
either infected with bacteria or treated with recombinant IsaB; autophagic flux and 
localization were then assessed with confocal microscopy. Detailed information about 
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bacteria, antibodies, cytokines, plasmids and recombinant IsaB are described in the 
Supplementary Materials and Methods.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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TNF-α Tumor necrosis factor alpha
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CFU Colony-forming unit
GAS Group A Streptococcus
MIP-2 Macrophage inflammatory protein-2
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Figure 1. Transmissible MRSA252 induces IsaB expression and inflammation in vivo
(a) The right ears of mice were injected intradermally with MRSA(0) or MRSA(1) (1 × 107 
CFU). Ear thickness was measured and calculated as a percentage, compared to the PBS-
injected control, on days 1, 2, and 5 after MRSA injection. Representative images of skin 
inflammation are shown. Bar = 1 cm. (b) MIP-2 production in mice infected with MRSA(1) 
was measured by ELISA and normalized to that in mice infected with MRSA(0). (c) The 
infected ears on day 5 were homogenized for counting MRSA colonies. Data are expressed 
as the mean ± SEM (n=8). (d) The samples in (c) were subjected to immunoblotting. An 
arrow indicates IsaB protein, which has a molecular weight of 20 kDa.
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Figure 2. IsaB is involved in autophagic flux inhibition in cells
(a) HeLa cells harboring GFP-MAP1LC3 or (b) RFP-GFP- MAP1LC3 were infected with 
wild-type (WT) S. aureus or an isogenic deletion mutant (ΔisaB) (MOI of 200) for 6 h to 
observe GFP-MAP1LC3 puncta and autophagic flux using confocal microscopy. Rapamycin 
(0.5 μM) or BafA1 (100 nM) are used as a control for autophagy induction and inhibition, 
respectively. Bar = 10 μm. (c) The percentage of autophagosomes (RFP+GFP+) and 
autolysosomes (RFP+GFP−) in each cell as (b) were quantitated from a pool of at least 10 
images. (d) Human macrophage-like THP-1 cells were infected with wild-type (WT) S. 
aureus or an isogenic deletion mutant (ΔisaB) (MOI of 200) for 6 hrs in the presence or 
absence of 20 μM CQ. The accumulation of SQSTM1 and MAP1LC3-II in infected THP-1 
cells was examined by immunoblotting. (e) The quantification of SQSTM1 protein levels 
and autophagic flux is shown. The results are expressed as the mean±SEM from 3 
independent experiments.
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Figure 3. Autophagic flux inhibition increases the viability of S. aureus in host cells
HeLa cells harboring Lamp1-RFP (red) were infected with SYTO (green)-labeled wild-type 
(WT) S. aureus or an isogenic deletion mutant (ΔisaB) (MOI of 200) for 5 hrs in the absence 
or presence of BafA1 (100 nM) or rapamycin (0.5 μM). The cells were then fixed and 
observed under confocal microscopy. Bar = 10 μm. (b) Colocalization of bacteria and 
Lamp1 in cells as (a) was quantitated. (c) Human macrophage-like THP-1 cells were 
infected with SYTO (green)-labeled bacteria (MOI of 200) for 6 hrs with or without BafA1 
(100 nM) or Rapamycin (0.5 μM). The infected cells were harvested to determine the 
amount of bacteria in the host cells using flow cytometer. (d) The percentage of bacteria in 
cells was quantitated by FlowJo software and analyzed by Prism 5.0. (e) Colony formation 
by the cells infected with bacteria (MOI of 200) for 6 hrs in the presence or absence of 
BafA1 was quantified. (f) The secretion of the inflammatory cytokine TNF-α and (g) the 
mRNA levels of Tnf-α and Il-8 in infected THP-1 cells were determined by ELISA and real-
time PCR, respectively. The results are expressed as the mean ± SEM from 3 independent 
experiments.
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Figure 4. IsaB expression in clinical MRSA isolates is associated with autophagy and 
inflammation in THP-1 cells
(a) Clinical MRSA isolates were lysed to examine IsaB protein levels by immunoblotting. 
(b) Human macrophage-like THP-1 cells were infected with clinical MRSA isolates (MOI 
of 10) for 6 h in the presence (+) or absence (-) of 20 μM CQ for 2 h prior to harvesting. 
Cells were then lysed to examine SQSTM1, MAP1LC3-II protein levels by immunoblotting. 
Because the clinical MRSA isolate C1 shows the lowest IsaB expression of the 5 tested 
clinical MRSA isolates, the protein levels of (c) SQSTM1 and (d) MAP1LC3-II in the 
infected cells were quantified using the C1-infected cells as a control. (e) Colony formation, 
(f) secretion of TNF-α and (g) the mRNA levels of Tnf-α and Il-8 in infected THP-1 cells 
were determined by ELISA and real-time PCR, respectively. The results are expressed as the 
mean ± SEM from 3 independent experiments.
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Figure 5. IsaB inhibits autophagic flux and triggers inflammation in vivo
(a) The isaB wild-type (WT) or the isaB deletion (ΔisaB) S. aureus strain (1 × 107 CFU) was 
subcutaneously injected into the ears of mice (3 mice for each group). The ear thickness of 
each infected mouse was measured every day for 3 days. Representative images of ear skin 
inflammation are shown. Bar = 1 cm. (b) Infected right ears were homogenized on day 3 
after injection to determine the level of bacterial colonization. (c) The homogenized ears 
were analyzed for SQSTM1 and MAP1LC3-II protein levels. (d) Quantified SQSTM1 and 
MAP1LC3-II protein levels in infected ears are shown. (e) The dorsal skin of mice was 
injected intradermally with wild type (WT) or isaB-deletion mutant (ΔisaB) strain (4 mice 
for each group). Representative images of dorsal skin lesions after 3 days of infection are 
shown and were quantified with ImageJ software. Bar = 0.5 cm. (f) Colonization by wild-
type (WT) or isaB-deletion (ΔisaB) strain in the skin was counted on day 3 after injection. 
The results are expressed as the mean ± SEM.
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Figure 6. Recombinant IsaB diminishes autophagic flux and reconstitutes the virulence of the 
isaB-deficient strain and GAS
(a) HeLa cells harboring GFP-MAP1LC3 were treated with recombinant IsaB for 6 h and 
fixed to determine the effect of IsaB on GFP-MAP1LC3-II puncta, using florescence 
microscopy. BafA1 (100 nM) is used as a control for autophagic flux inhibition. Bar = 10 
μm. (b) MEF cells stably harboring GFP-MAP1LC3 were treated with recombinant IsaB for 
6 h. Protein levels of GFP-MAP1LC3-II, GFP, and SQSTM1 in treated cells were 
determined by immunoblotting. Protein levels were normalized with ACTB and are shown 
as quantified in the right panel. (c) Mice were injected with the isaB deletion strain (1 × 107 
CFU) and 50 μg recombinant MRSA IsaB (R-IsaB ± ΔisaB) or GFP (R-GFP ±V isaB). 
Lesion sizes were quantified on day 3 after injection using ImageJ software (n = 4). Bar = 
0.5 cm. (d) Bacterial survival on day 3 after injection was quantified in agar plates. (e) Live 
GAS NZ131 (1 × 107 CFU) mixed with 50 μg recombinant IsaB (R-IsaB+GAS) or GFP (R-
GFP+GAS) was subcutaneously injected into the dorsal skin of mice. Lesion sizes and (f) 
bacterial survival on day 3 after injection were quantified using ImageJ software. 
Representative images of dorsal skin lesion are shown. Bar = 0.5 cm. The results are 
expressed as the mean ± SEM.
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